4.6 Editorial Material

Aducanumab and Accelerated Approval: Where Do We Go From Here?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

Revisiting FDA Approval of Aducanumab

G. Caleb Alexander et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Fulfilling the Mandate of the US Food and Drug Administration's Accelerated Approval Pathway The Need for Reforms

Bishal Gyawali et al.

JAMA INTERNAL MEDICINE (2021)

Review Medicine, General & Internal

FDA Approval and Regulation of Pharmaceuticals, 1983-2018

Jonathan J. Darrow et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

Bishal Gyawali et al.

JAMA INTERNAL MEDICINE (2019)

Editorial Material Medicine, General & Internal

Accelerated Approval and Expensive Drugs - A Challenging Combination

Walid F. Gellad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Editorial Material Medicine, General & Internal

Surrogate Outcomes in Clinical Trials A Cautionary Tale

Staffan Svensson et al.

JAMA INTERNAL MEDICINE (2013)

Editorial Material Medicine, General & Internal

Reputation and Precedent in the Bevacizumab Decision

Daniel Carpenter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)